Estrogen Receptor Negative and Progesterone Receptor Positive Breast Carcinomas—How Frequent are they?-Reference-Cited by-同舟云学术

Estrogen Receptor Negative and Progesterone Receptor Positive Breast Carcinomas—How Frequent are they?

Published:2011-01-26 Issue:3 Volume:17 Page:663-668
ISSN:1219-4956
Container-title:Pathology & Oncology Research
language:en
Short-container-title:Pathol. Oncol. Res.

Author:

Cserni Gábor,Francz Monika,Kálmán Endre,Kelemen Gyöngyi,Komjáthy Detre Csaba,Kovács Ilona,Kulka Janina,Sarkadi László,Udvarhelyi Nóra,Vass László,Vörös András

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine,Pathology and Forensic Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12253-011-9366-y.pdf

Reference9 articles.

1. Moshin SK, Weiss H, Havinghurst T et al (2004) Progesterone receptor by immunohistochemistry and clinical outcome in breast cancer: a validation study. Mod Pathol 17:1545–1554

2. Viale G, Regan MM, Maiorano E et al (2008) Chemoendocrine compared with endocrine adjuvant therapies for node-negative breast cancer: predictive value of centrally reviewed expression of estrogen and progesterone receptors—International Breast Cancer Study Group. J Clin Oncol 26:1404–1410

3. Nadji M, Gomez-Ferenandez C, Ganjei-Azar P et al (2005) Immunohistochemistry of estrogen and progesterone receptors reconsidered: experience with 5, 993 breast cancers. Am J Clin Pathol 123:21–27

4. De Maeyer L, Van Limbergen E, De Nys K et al (2008) Does estrogen receptor-negative/progesterone receptor-positive breast carcinoma exist? J Clin Oncol 26:335–340

5. Goldhirsch A, Glick JH, Gelber RD et al (2005) Meeting highlights: International expert consensus on the primary therapy of early breast cancer 2005. Ann Oncol 16:1569–1583

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A prospective cohort study of clinical characteristics and outcomes in Chinese patients with estrogen receptor-negative/progesterone receptor-positive early breast cancer;Breast Cancer Research and Treatment;2023-05-18

2. Clinical considerations for estrogen receptor-negative/progesterone receptor-positive/HER2-negative (ER−PR+HER2−) breast cancer;Translational Breast Cancer Research;2023-01

3. A prospective cohort study of clinical characteristics and outcome of Chinese patients with estrogen receptor-negative/progesterone receptor-positive early breast cancer;2022-12-21

4. The Prognosis and Predictive Value of Estrogen Negative/Progesterone Positive (ER−/PR+) Phenotype: Experience of 1159 Primary Breast Cancer from a Single Institute;The Breast Journal;2022-05-17

5. Estrogen receptor-negative/progesterone receptor-positive and her-2-negative breast cancer might no longer be classified as hormone receptor-positive breast cancer;International Journal of Clinical Oncology;2022-04-10